Yongbo Yang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yongbo Yang has a total of 89 co-authors. Here are the top co-authors by number of shared publications:
Yi Wang
Department of Neurosurgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, China
5 shared publicationsChunhua Hang
Department of Neurosurgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of China
4 shared publications- Zhiyong Shi
Department of Neurosurgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of China
4 shared publications Lingyun Wu
Department of Neurosurgery, Nanjing Drum Tower Hospital, Nanjing University Medical School, Nanjing, People’s Republic of China
3 shared publications- Chao You
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China
2 shared publications Dong Zhang
Department of Neurosurgery, Beijing Hospital, Beijing, China
2 shared publications
Latest Publications
- 2 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 392
The research of subdural effusion collection complicating cerebral revascularization following ventriculoperitoneal shunting in adults with hemorrhagic moyamoya disease: A retrospective case series
Ventriculoperitoneal shunting (VPS) helps reduce intracranial pressure and alleviate clinical symptoms caused by hydrocephalus in hemorrhagic Moyamoya disease (MMD). To date, no literature describes the occurrence of subdural fluid collection (SDFC) in hemorrhagic MMD patients undergoing VPS prior to cerebral revascularization. This report aims to explore the potential pathological mechanisms underlying SDFC following cerebral revascularization after prior VPS, and to provide effective strategies for future prevention. Clinical data of hemorrhagic MMD patients undergoing VPS prior to bypass admitted to our hospital from 2021 January and 2024 December were selected. Medical records were reviewed to analyze patient characteristics and the entire disease course. Among the 7 patients (9 cases), postoperative SDFC occurred in 7 cases (7/9, 77.8%), located contralateral to the shunt in 6 cases (6/7, 85.7%) and ipsilateral to the surgical side in 1 case (1/7, 14.3%), with onset mostly within 1 day after surgery. Among these 7 patients, 2 underwent subdural drilling and drainage due to significant mass effect caused by the effusion. One of these patients developed herniation with decreased consciousness and notable midline shift, and symptoms gradually improved after subdural drainage. Durin-g short-term clinical follow-up (postoperative period < 12 months), recurrent hemorrhage occurred in 1 out of 9 cases, while no cases of cerebral infarction or seizures were observed. CT angiography (CTA) revealed occlusion of the bypass graft in 2 out of 6 direct bypass cases. Through the findings of this study and literature review, we observe that cerebral revascularization performed during the late phase of VPS may induce SDFC complications through multiple mechanisms. Future implementation of early intervention may effectively reduce the risk of adverse events and improve surgical outcomes.
- 2 May 2026
- Published by Springer Nature in Neurosurgical Review
- Vol. 49 (1) , 392
The research of subdural effusion collection complicating cerebral revascularization following ventriculoperitoneal shunting in adults with hemorrhagic moyamoya disease: A retrospective case series
Ventriculoperitoneal shunting (VPS) helps reduce intracranial pressure and alleviate clinical symptoms caused by hydrocephalus in hemorrhagic Moyamoya disease (MMD). To date, no literature describes the occurrence of subdural fluid collection (SDFC) in hemorrhagic MMD patients undergoing VPS prior to cerebral revascularization. This report aims to explore the potential pathological mechanisms underlying SDFC following cerebral revascularization after prior VPS, and to provide effective strategies for future prevention. Clinical data of hemorrhagic MMD patients undergoing VPS prior to bypass admitted to our hospital from 2021 January and 2024 December were selected. Medical records were reviewed to analyze patient characteristics and the entire disease course. Among the 7 patients (9 cases), postoperative SDFC occurred in 7 cases (7/9, 77.8%), located contralateral to the shunt in 6 cases (6/7, 85.7%) and ipsilateral to the surgical side in 1 case (1/7, 14.3%), with onset mostly within 1 day after surgery. Among these 7 patients, 2 underwent subdural drilling and drainage due to significant mass effect caused by the effusion. One of these patients developed herniation with decreased consciousness and notable midline shift, and symptoms gradually improved after subdural drainage. Durin-g short-term clinical follow-up (postoperative period < 12 months), recurrent hemorrhage occurred in 1 out of 9 cases, while no cases of cerebral infarction or seizures were observed. CT angiography (CTA) revealed occlusion of the bypass graft in 2 out of 6 direct bypass cases. Through the findings of this study and literature review, we observe that cerebral revascularization performed during the late phase of VPS may induce SDFC complications through multiple mechanisms. Future implementation of early intervention may effectively reduce the risk of adverse events and improve surgical outcomes.
- Open Access
- 26 February 2026
- Published by Springer Nature in Chinese Neurosurgical Journal
- Vol. 12 (1) , 5
A novel superficial temporal artery patency concept of cerebral revascularization for patients with moyamoya disease: a multicenter study
Background: To summarize the clinical and radiological outcomes of a novel cerebral revascularization technique based on the superficial temporal artery patency concept (STAPC) in patients with moyamoya disease (MMD). Methods: A retrospective review was conducted of adult patients with MMD treated at Beijing Hospital and Nanjing Drum Tower Hospital between January 2019 and December 2021. The cohort comprised 170 patients who underwent superficial temporal artery–middle cerebral artery bypass with encephalo-duro-arterio-synangiosis (EDAS) (STA-MCA/EDAS), and 133 who underwent EDAS alone. Radiological follow-up included computed tomography (CT) angiography (CTA) to assess bypass patency and CT perfusion (CTP) for hemodynamic staging at 3 and 12 months post-revascularization. Clinical follow-up recorded perioperative complications and recurrent stroke events that occurred > 12 months postoperativerly. Results: Of the 303 patients, 37 cases (12.21%) had perioperative complications including 27 cases (15.9%) in the STA-MCA/EDAS group and 10 cases (7.5%) in the EDAS group. Perfusion improvement was observed in 23.76% of patients (25.7% in the STA-MCA/EDAS group and 17.8% in the EDAS group) at 3 months postsurgical, and in 40.17% of patients (48.68% in the STA-MCA/EDAS group and 24.39% in the EDAS group) at 12 months postsurgical. Bypass patency was observed in 95.29% of patients (96.1% in the STA-MCA/EDAS group and 93.5% in the EDAS group) at 3 months postoperative, and in 96.43% patients (95.2% in the STA-MCA/EDAS group and 97.1% in the EDAS group) at 12 months postoperative. Of the 249 patients with a median follow-up period of 50 months (range 12–70 months), 40 cases (16.06%, 3.85% per year) had recurrent stroke events including 22 (15.41%, 3.69% per year) in the STA-MCA/EDAS group and 18 (16.67%, 3.91% per year) in the EDAS group. Conclusions: Cerebral revascularization using STAPC is an acceptable surgical strategy for preventing stroke recurrence in patients with MMD.
- 26 February 2026
- Published by Springer Nature in Chinese Neurosurgical Journal
- Vol. 12 (1) , 5
Open AccessA novel superficial temporal artery patency concept of cerebral revascularization for patients with moyamoya disease: a multicenter study
Background: To summarize the clinical and radiological outcomes of a novel cerebral revascularization technique based on the superficial temporal artery patency concept (STAPC) in patients with moyamoya disease (MMD). Methods: A retrospective review was conducted of adult patients with MMD treated at Beijing Hospital and Nanjing Drum Tower Hospital between January 2019 and December 2021. The cohort comprised 170 patients who underwent superficial temporal artery–middle cerebral artery bypass with encephalo-duro-arterio-synangiosis (EDAS) (STA-MCA/EDAS), and 133 who underwent EDAS alone. Radiological follow-up included computed tomography (CT) angiography (CTA) to assess bypass patency and CT perfusion (CTP) for hemodynamic staging at 3 and 12 months post-revascularization. Clinical follow-up recorded perioperative complications and recurrent stroke events that occurred > 12 months postoperativerly. Results: Of the 303 patients, 37 cases (12.21%) had perioperative complications including 27 cases (15.9%) in the STA-MCA/EDAS group and 10 cases (7.5%) in the EDAS group. Perfusion improvement was observed in 23.76% of patients (25.7% in the STA-MCA/EDAS group and 17.8% in the EDAS group) at 3 months postsurgical, and in 40.17% of patients (48.68% in the STA-MCA/EDAS group and 24.39% in the EDAS group) at 12 months postsurgical. Bypass patency was observed in 95.29% of patients (96.1% in the STA-MCA/EDAS group and 93.5% in the EDAS group) at 3 months postoperative, and in 96.43% patients (95.2% in the STA-MCA/EDAS group and 97.1% in the EDAS group) at 12 months postoperative. Of the 249 patients with a median follow-up period of 50 months (range 12–70 months), 40 cases (16.06%, 3.85% per year) had recurrent stroke events including 22 (15.41%, 3.69% per year) in the STA-MCA/EDAS group and 18 (16.67%, 3.91% per year) in the EDAS group. Conclusions: Cerebral revascularization using STAPC is an acceptable surgical strategy for preventing stroke recurrence in patients with MMD.
- 23 October 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-12
Cerebral revascularization with one-stage and two-stage aneurysm trapping for complex intracranial aneurysms in anterior circulation: a single-center retrospective cohort study
To present results of complex intracranial aneurysms (CIAs) underwent extracranial-intracranial (EC-IC) bypass with one-stage and two-stage aneurysm trapping in anterior circulation and share our experience. The author retrospectively reviewed 53 patients with CIAs underwent EC-IC bypass with different therapies of aneurysm trapping from Jan. 2018 to Dec 2020. Ballon occlusion testing (BOT) was performed to assess collateral circulation. In general, CIAs was operated by one-stage trapping, which was characterized by simultaneous implementation of aneurysm trapping and EC-IC bypass. However, CIAs failing to BOT or harboring important perforators was performed by two-stage trapping, which involved subsequent delay in performing aneurysm trapping based on CIAs change after EC-IC bypass. Clinical variables, postoperative complications, and follow-up outcomes were presented. Of the 53 patients, 28 patients completed the one-stage aneurysm trapping, and 25 patients completed two-stage aneurysm trapping. There was significant difference in patients experiencing new cerebral infarction between patients with one-stage and two-stage aneurysm trapping (21.4% vs. 4.0%, P = 0.049). When discharged, there was significant difference in CIAs disappeared between patients with one-stage and two-stage aneurysm trapping (100.0% vs. 24.0%, P < 0.001). CIAs without one-stage aneurysm trapping achieved complex aneurysm changes after revascularization, including aneurysm disappeared, unchanged, and enlarged in 6 cases, 9 cases, and 10 cases. Out of 18 CIAs demanding two-staged aneurysm trapping, aneurysm disappeared in 17 cases and got smaller in 1 case. At the final follow-up with average of 58 months, there was no significant difference in aneurysm change between patients with one-stage and two-stage aneurysm trapping (P = 0.312). No new ischemic and hemorrhagic events developed. EC-IC bypass with one-stage aneurysm trapping was an effective option for CIAs although with high risk of operation-related infarction. EC-IC bypass with two-stage aneurysm trapping was an alternative treatment for selected CIAs.
- 23 October 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 1-12
Cerebral revascularization with one-stage and two-stage aneurysm trapping for complex intracranial aneurysms in anterior circulation: a single-center retrospective cohort study
To present results of complex intracranial aneurysms (CIAs) underwent extracranial-intracranial (EC-IC) bypass with one-stage and two-stage aneurysm trapping in anterior circulation and share our experience. The author retrospectively reviewed 53 patients with CIAs underwent EC-IC bypass with different therapies of aneurysm trapping from Jan. 2018 to Dec 2020. Ballon occlusion testing (BOT) was performed to assess collateral circulation. In general, CIAs was operated by one-stage trapping, which was characterized by simultaneous implementation of aneurysm trapping and EC-IC bypass. However, CIAs failing to BOT or harboring important perforators was performed by two-stage trapping, which involved subsequent delay in performing aneurysm trapping based on CIAs change after EC-IC bypass. Clinical variables, postoperative complications, and follow-up outcomes were presented. Of the 53 patients, 28 patients completed the one-stage aneurysm trapping, and 25 patients completed two-stage aneurysm trapping. There was significant difference in patients experiencing new cerebral infarction between patients with one-stage and two-stage aneurysm trapping (21.4% vs. 4.0%, P = 0.049). When discharged, there was significant difference in CIAs disappeared between patients with one-stage and two-stage aneurysm trapping (100.0% vs. 24.0%, P < 0.001). CIAs without one-stage aneurysm trapping achieved complex aneurysm changes after revascularization, including aneurysm disappeared, unchanged, and enlarged in 6 cases, 9 cases, and 10 cases. Out of 18 CIAs demanding two-staged aneurysm trapping, aneurysm disappeared in 17 cases and got smaller in 1 case. At the final follow-up with average of 58 months, there was no significant difference in aneurysm change between patients with one-stage and two-stage aneurysm trapping (P = 0.312). No new ischemic and hemorrhagic events developed. EC-IC bypass with one-stage aneurysm trapping was an effective option for CIAs although with high risk of operation-related infarction. EC-IC bypass with two-stage aneurysm trapping was an alternative treatment for selected CIAs.
- Open Access
- 19 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
The intraoperative hemodynamic and clinical research of three direct bypasses in moyamoya disease a prospective cohort of 98 cases
The goal of this study was to investigate clinical and hemodynamic differences in moyamoya disease patients underwent direct bypass using one donor-one recipient (1D1R), one donor-two recipients (1D2R), and two donors-two recipients (2D2R) bypass. To the authors’ knowledge, this represents the largest series reported to date. Clinical and radiographic data were collected for 98 patients using 1D1R (28 cases), 1D2R (46 cases), and 2D2R (24 cases) bypasses. The patients’ demographic information, clinical presentations, associated medical conditions, intraoperative hemodynamics, and postoperative hemispheric perfusion were obtained from reviewing medical records, intraoperative microvascular Doppler ultrasonography, and CT perfusion scans. There was no significant difference in the incidence of postoperative complication, bypass vessel patency, and good neovascularization among the 3 groups (P > 0.05). When postoperative complications occurred, patients in the 1D2R group had a lower modified Rankin Scale (mRS) score and a shorter duration of symptoms compared to those in the 1D1R group (P < 0.05). A significant difference was observed in the intraoperative mean velocity values of the donor vessel and the recipient artery (RA) in the parietal lobe among the three groups, with the 1D1R group showing the highest values (P < 0.05). Under blood pressure control, there was significant difference in the volumes of the hypoperfusion area, infarct core, and penumbra among the three groups (P < 0.05). The application of 1D1R, 1D2R, and 2D2R techniques resulted in distinct clinical and hemodynamic outcomes. Patients containing dual RAs were likely to have more extensive perfusion changes and better prognosis in the event of surgical complications.
- 19 August 2025
- Published by Springer Nature in Scientific Reports
- Vol. 15 (1) , 1-12
Open AccessThe intraoperative hemodynamic and clinical research of three direct bypasses in moyamoya disease a prospective cohort of 98 cases
The goal of this study was to investigate clinical and hemodynamic differences in moyamoya disease patients underwent direct bypass using one donor-one recipient (1D1R), one donor-two recipients (1D2R), and two donors-two recipients (2D2R) bypass. To the authors’ knowledge, this represents the largest series reported to date. Clinical and radiographic data were collected for 98 patients using 1D1R (28 cases), 1D2R (46 cases), and 2D2R (24 cases) bypasses. The patients’ demographic information, clinical presentations, associated medical conditions, intraoperative hemodynamics, and postoperative hemispheric perfusion were obtained from reviewing medical records, intraoperative microvascular Doppler ultrasonography, and CT perfusion scans. There was no significant difference in the incidence of postoperative complication, bypass vessel patency, and good neovascularization among the 3 groups (P > 0.05). When postoperative complications occurred, patients in the 1D2R group had a lower modified Rankin Scale (mRS) score and a shorter duration of symptoms compared to those in the 1D1R group (P < 0.05). A significant difference was observed in the intraoperative mean velocity values of the donor vessel and the recipient artery (RA) in the parietal lobe among the three groups, with the 1D1R group showing the highest values (P < 0.05). Under blood pressure control, there was significant difference in the volumes of the hypoperfusion area, infarct core, and penumbra among the three groups (P < 0.05). The application of 1D1R, 1D2R, and 2D2R techniques resulted in distinct clinical and hemodynamic outcomes. Patients containing dual RAs were likely to have more extensive perfusion changes and better prognosis in the event of surgical complications.
- Open Access
- 15 August 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1632626
Clinical and hemodynamic outcomes of side-to-side anastomosis in superficial temporal artery-middle cerebral artery bypass for adult patients with moyamoya disease: a prospective cohort study
Objective: Superficial temporal artery-middle cerebral artery (STA-MCA) bypass, characterized by side-to-side (S-S) anastomosis, has been beneficial in reducing the incidence of postoperative complications and recurrent stroke in patients with moyamoya disease (MMD). However, the safety and efficacy of this unconventional S-S procedure remain unclear. This research aimed to investigate the clinical and hemodynamic outcomes associated with the S-S technique.Methods: Clinical and radiographic data were collected from 50 adult patients with MMD (50 hemispheres), including 23 cases treated with S-S anastomosis and 27 cases treated with end-to-side (E-S) STA-MCA bypass. The patients’ demographic information, clinical presentation, associated medical conditions, intraoperative hemodynamics, postoperative hemispheric perfusion status, and clinical course were obtained through a review of medical records, intraoperative microvascular Doppler ultrasonography (MDU), and postoperative CT perfusion (CTP) imaging.Results: There was no significant difference between the S-S and E-S groups in baseline characteristics, postoperative complications, bypass patency rate, neovascularization, and modified Rankin Scale (mRS) scores (p > 0.05). However, significant differences were noted in bypass time and anastomosis size between the E-S and S-S groups (p < 0.001). Intraoperative MDU analysis demonstrated that the mean velocity value (MVV) of the recipient artery entering the Sylvian fissure (RA.ES) and the MVV fold change in donor vessels were significantly higher in the S-S group compared to the E-S group (p < 0.05). Postoperative CTP analysis showed no difference in the volume of the infarct core, hypoperfusion, and penumbra between the groups (p > 0.05).Conclusion: The S-S technique demonstrated a different intraoperative self-flow regulation capacity compared to the traditional E-S technique, but it showed no superiority in postoperative hemispheric perfusion and clinical outcomes. The choice of bypass procedure should be individualized.
- 15 August 2025
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 16, 1632626
Open AccessClinical and hemodynamic outcomes of side-to-side anastomosis in superficial temporal artery-middle cerebral artery bypass for adult patients with moyamoya disease: a prospective cohort study
Objective: Superficial temporal artery-middle cerebral artery (STA-MCA) bypass, characterized by side-to-side (S-S) anastomosis, has been beneficial in reducing the incidence of postoperative complications and recurrent stroke in patients with moyamoya disease (MMD). However, the safety and efficacy of this unconventional S-S procedure remain unclear. This research aimed to investigate the clinical and hemodynamic outcomes associated with the S-S technique.Methods: Clinical and radiographic data were collected from 50 adult patients with MMD (50 hemispheres), including 23 cases treated with S-S anastomosis and 27 cases treated with end-to-side (E-S) STA-MCA bypass. The patients’ demographic information, clinical presentation, associated medical conditions, intraoperative hemodynamics, postoperative hemispheric perfusion status, and clinical course were obtained through a review of medical records, intraoperative microvascular Doppler ultrasonography (MDU), and postoperative CT perfusion (CTP) imaging.Results: There was no significant difference between the S-S and E-S groups in baseline characteristics, postoperative complications, bypass patency rate, neovascularization, and modified Rankin Scale (mRS) scores (p > 0.05). However, significant differences were noted in bypass time and anastomosis size between the E-S and S-S groups (p < 0.001). Intraoperative MDU analysis demonstrated that the mean velocity value (MVV) of the recipient artery entering the Sylvian fissure (RA.ES) and the MVV fold change in donor vessels were significantly higher in the S-S group compared to the E-S group (p < 0.05). Postoperative CTP analysis showed no difference in the volume of the infarct core, hypoperfusion, and penumbra between the groups (p > 0.05).Conclusion: The S-S technique demonstrated a different intraoperative self-flow regulation capacity compared to the traditional E-S technique, but it showed no superiority in postoperative hemispheric perfusion and clinical outcomes. The choice of bypass procedure should be individualized.
- 23 July 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 580
Long-term clinical and radiological outcomes of extracranial-intracranial bypass in hemorrhagic patients with Moyamoya disease: A single-center observational study of 45 cases
The long-term effect of superficial temporal artery-middle cerebral artery (STA-MCA) bypass and corresponding hemodynamics in hemorrhagic moyamoya disease (MMD) remained unclear. This study aimed to investigate the incidence of long-term rebleeding events, bypass patency, neovascularization, and changes in hemispheric prefusion in hemorrhagic MMD patients. Clinical and radiographic images for 35 hemorrhagic MMD patients (45 hemispheres) using STA-MCA bypass were recorded. The patients' demographic information, clinical presentation, associated medical conditions, hemispheric perfusion status, and clinical course were obtained from reviewing medical records, cerebral angiography, and CT perfusion (CTP) during long-term follow-up. Of the 45 cases with an average follow-up of 38 months, 7 cases (15.5%, 2.08% per year) experienced new cerebral hemorrhages. The latest cerebral angiography indicated patent bypass in 32 cases (71.1%) and Matsushima grade A in 16 cases (35.6%). Distribution analysis of modified Suzuki stages and moyamoya vessels patterns showed significant changes (P < 0.05), with a higher proportion of patients progressing to advanced stages and a decrease in moyamoya vessels. There was a significant improvement in neurological outcomes (P = 0.004), with 80.0% of cases achieving normal neurological function. Long-term CTP analysis revealed no significant differences in rCBF compared to preoperative values (P > 0.05). However, rCBV significantly decreased in the caudate nucleus, parietal lobe, and striatum (P < 0.05). Significant decrease in rMTT and rTmax parameters were noted in several regions, including the genu of the corpus callosum, caudate nucleus, dorsal thalamus, and multiple cortical regions, indicating a reduction in microcirculation time (P < 0.05). STA-MCA bypass could improve long-term neurological outcomes in hemorrhagic MMD patients, facilitating advancements in Suzuki stages and reducing moyamoya vessels. Long-term CTP results indicated a slight decrease in rCBF in several areas and shortened microcirculation time. Not applicable.
- 23 July 2025
- Published by Springer Nature in Neurosurgical Review
- Vol. 48 (1) , 580
Long-term clinical and radiological outcomes of extracranial-intracranial bypass in hemorrhagic patients with Moyamoya disease: A single-center observational study of 45 cases
The long-term effect of superficial temporal artery-middle cerebral artery (STA-MCA) bypass and corresponding hemodynamics in hemorrhagic moyamoya disease (MMD) remained unclear. This study aimed to investigate the incidence of long-term rebleeding events, bypass patency, neovascularization, and changes in hemispheric prefusion in hemorrhagic MMD patients. Clinical and radiographic images for 35 hemorrhagic MMD patients (45 hemispheres) using STA-MCA bypass were recorded. The patients' demographic information, clinical presentation, associated medical conditions, hemispheric perfusion status, and clinical course were obtained from reviewing medical records, cerebral angiography, and CT perfusion (CTP) during long-term follow-up. Of the 45 cases with an average follow-up of 38 months, 7 cases (15.5%, 2.08% per year) experienced new cerebral hemorrhages. The latest cerebral angiography indicated patent bypass in 32 cases (71.1%) and Matsushima grade A in 16 cases (35.6%). Distribution analysis of modified Suzuki stages and moyamoya vessels patterns showed significant changes (P < 0.05), with a higher proportion of patients progressing to advanced stages and a decrease in moyamoya vessels. There was a significant improvement in neurological outcomes (P = 0.004), with 80.0% of cases achieving normal neurological function. Long-term CTP analysis revealed no significant differences in rCBF compared to preoperative values (P > 0.05). However, rCBV significantly decreased in the caudate nucleus, parietal lobe, and striatum (P < 0.05). Significant decrease in rMTT and rTmax parameters were noted in several regions, including the genu of the corpus callosum, caudate nucleus, dorsal thalamus, and multiple cortical regions, indicating a reduction in microcirculation time (P < 0.05). STA-MCA bypass could improve long-term neurological outcomes in hemorrhagic MMD patients, facilitating advancements in Suzuki stages and reducing moyamoya vessels. Long-term CTP results indicated a slight decrease in rCBF in several areas and shortened microcirculation time. Not applicable.
- 19 December 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 40 (4) , 451-465
GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. Immune inflammation is associated with the occurrence and development of MMD. However, the mechanisms underlying the formation of the abnormal vascular network remain unclear. Twenty-eight patients with MMD, 26 ischemic stroke patients, and 26 unrelated healthy volunteers were enrolled in this study The data showed that the levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) were higher in MMD patients than in healthy controls (P <0.01), and GM-CSF was mainly from Th1 and Th17 cells in MMD. We found that increased GM-CSF drove monocytes to secrete a series of cytokines associated with angiogenesis, inflammation, and chemotaxis. In summary, our findings demonstrate for the first time the important involvement of GM-CSF in MMD and that GM-CSF is an important factor in the formation of abnormal vascular networks in MMD.
- 19 December 2023
- Published by Springer Nature in Neuroscience Bulletin
- Vol. 40 (4) , 451-465
GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease
Moyamoya disease (MMD) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. Immune inflammation is associated with the occurrence and development of MMD. However, the mechanisms underlying the formation of the abnormal vascular network remain unclear. Twenty-eight patients with MMD, 26 ischemic stroke patients, and 26 unrelated healthy volunteers were enrolled in this study The data showed that the levels of granulocyte-macrophage colony-stimulating factor (GM-CSF) were higher in MMD patients than in healthy controls (P <0.01), and GM-CSF was mainly from Th1 and Th17 cells in MMD. We found that increased GM-CSF drove monocytes to secrete a series of cytokines associated with angiogenesis, inflammation, and chemotaxis. In summary, our findings demonstrate for the first time the important involvement of GM-CSF in MMD and that GM-CSF is an important factor in the formation of abnormal vascular networks in MMD.
- Open Access
- 4 October 2023
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (10) , e1419
New era for intracerebral haemorrhage management: Lessons from INTERACT3
- 4 October 2023
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (10) , e1419
Open AccessNew era for intracerebral haemorrhage management: Lessons from INTERACT3
- Open Access
- 5 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3855
Intraoperative Hemodynamics of Parasylvian Cortical Arteries for Predicting Postoperative Symptomatic Cerebral Hyperperfusion after Direct Revascularization in Patients with Moyamoya Disease: A Preliminary Study
Objective. The search for methods by which to predict the risks of cerebral hyperperfusion syn-drome (CHS) in adults with moyamoya disease (MMD), including those utilizing new biomarkers, still deserves further research. The objective of this study was to investigate the association between the hemodynamics of parasylvian cortical arteries (PSCAs) and postoperative CHS. Methods. A consecutive number of adults with MMD who had undergone direct bypass between September 2020 and December 2022 were recruited. Intraoperative microvascular doppler ultrasonography (MDU) was performed to evaluate the hemodynamics of PSCAs. The intraoperative flow direction, mean value of velocity (MVV) of recipient artery (RA) and bypass graft were recorded. According to flow direction after bypass, RA was divided into entering sylvian (RA.ES) and leaving sylvian (RA.LS) subtypes. Univariate, multivariate, and ROC analyses of the risk factors for postoperative CHS were performed. Results. A total of 16 (15.09%) cases in 106 consecutive hemispheres (101 patients) sat-isfied the postoperative CHS criteria. According to univariate analysis, advanced Suzuki stage, MVV of RA before bypass, and fold increase of MVV in RA.ES after bypass were significantly associated with postoperative CHS (p < 0.05). Multivariate analysis indicated that left-operated hemisphere (OR (95%CI), 4.58 (1.05–19.97), p = 0.043), advanced Suzuki stage (OR (95%CI), 5.47 (1.99–15.05), p = 0.017), and fold increase of MVV in RA.ES (OR (95%CI), 1.17 (1.06–1.30), p = 0.003) were statistically significantly associated with the occurrence of CHS. The cut-off value of fold increase of MVV in RA.ES was 2.7-fold (p < 0.05). Conclusions. Left-operated hemisphere, advanced Suzuki stage, and postoperative fold increase of MVV in RA.ES were potential risk factors for postoperative CHS. Intraoperative MDU was useful for evaluating hemodynamics and predicting CHS.
- 5 June 2023
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 12 (11) , 3855
Open AccessIntraoperative Hemodynamics of Parasylvian Cortical Arteries for Predicting Postoperative Symptomatic Cerebral Hyperperfusion after Direct Revascularization in Patients with Moyamoya Disease: A Preliminary Study
Objective. The search for methods by which to predict the risks of cerebral hyperperfusion syn-drome (CHS) in adults with moyamoya disease (MMD), including those utilizing new biomarkers, still deserves further research. The objective of this study was to investigate the association between the hemodynamics of parasylvian cortical arteries (PSCAs) and postoperative CHS. Methods. A consecutive number of adults with MMD who had undergone direct bypass between September 2020 and December 2022 were recruited. Intraoperative microvascular doppler ultrasonography (MDU) was performed to evaluate the hemodynamics of PSCAs. The intraoperative flow direction, mean value of velocity (MVV) of recipient artery (RA) and bypass graft were recorded. According to flow direction after bypass, RA was divided into entering sylvian (RA.ES) and leaving sylvian (RA.LS) subtypes. Univariate, multivariate, and ROC analyses of the risk factors for postoperative CHS were performed. Results. A total of 16 (15.09%) cases in 106 consecutive hemispheres (101 patients) sat-isfied the postoperative CHS criteria. According to univariate analysis, advanced Suzuki stage, MVV of RA before bypass, and fold increase of MVV in RA.ES after bypass were significantly associated with postoperative CHS (p < 0.05). Multivariate analysis indicated that left-operated hemisphere (OR (95%CI), 4.58 (1.05–19.97), p = 0.043), advanced Suzuki stage (OR (95%CI), 5.47 (1.99–15.05), p = 0.017), and fold increase of MVV in RA.ES (OR (95%CI), 1.17 (1.06–1.30), p = 0.003) were statistically significantly associated with the occurrence of CHS. The cut-off value of fold increase of MVV in RA.ES was 2.7-fold (p < 0.05). Conclusions. Left-operated hemisphere, advanced Suzuki stage, and postoperative fold increase of MVV in RA.ES were potential risk factors for postoperative CHS. Intraoperative MDU was useful for evaluating hemodynamics and predicting CHS.
- Open Access
Single-cell transcriptome analysis reveals the cellular atlas of human intracranial aneurysm and highlights inflammation features associated with aneurysm rupture
Intracranial aneurysm (IA) is pouch-like pathological dilations of cerebral arteries, which often affects middle-aged people and culminates in life-threatening hemorrhagic stroke. A deeper knowledge of the cellular and gene expression perturbations in human IA tissue deepens our understanding of disease mechanisms and facilitates developing pharmacological targets for unruptured IA. In this study, 21,332 qualified cells were obtained from cell-sparse ruptured and unruptured human IA tissues and a detailed cellular profile was determined, including conventional endothelial cells, smooth muscle cells (SMC), fibroblasts and the newly identified pericytes. Notably, striking proportion of immune cells were identified in IA tissue, with the number of monocyte/macrophages and neutrophils being remarkably higher in ruptured IA. By leveraging external datasets and machine learning algorithms, a subset of macrophages characterized by high expression of CCL3 and CXCL3, and transcriptional activation of NF-κB and HIVEP2 was identified as the cell most associated with IA rupture. Further, the interactome of CCL3/CXCL3 macrophages disclosed their role in regulating vascular cell survival and orchestrating inflammation. In summary, this study illustrated the profile and interactions of vascular and immune cells in human IA tissue and the opportunities for targeting local chronic inflammation.
Open AccessSingle-cell transcriptome analysis reveals the cellular atlas of human intracranial aneurysm and highlights inflammation features associated with aneurysm rupture
Intracranial aneurysm (IA) is pouch-like pathological dilations of cerebral arteries, which often affects middle-aged people and culminates in life-threatening hemorrhagic stroke. A deeper knowledge of the cellular and gene expression perturbations in human IA tissue deepens our understanding of disease mechanisms and facilitates developing pharmacological targets for unruptured IA. In this study, 21,332 qualified cells were obtained from cell-sparse ruptured and unruptured human IA tissues and a detailed cellular profile was determined, including conventional endothelial cells, smooth muscle cells (SMC), fibroblasts and the newly identified pericytes. Notably, striking proportion of immune cells were identified in IA tissue, with the number of monocyte/macrophages and neutrophils being remarkably higher in ruptured IA. By leveraging external datasets and machine learning algorithms, a subset of macrophages characterized by high expression of CCL3 and CXCL3, and transcriptional activation of NF-κB and HIVEP2 was identified as the cell most associated with IA rupture. Further, the interactome of CCL3/CXCL3 macrophages disclosed their role in regulating vascular cell survival and orchestrating inflammation. In summary, this study illustrated the profile and interactions of vascular and immune cells in human IA tissue and the opportunities for targeting local chronic inflammation.